Sign in

CIK 0002007919 · Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company

Inhibrx Biosciences, Inc.

Sign in to watch
Ticker
INBX
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
990613523
Phone
(858) 795-4220
Business address
11025 N. TORREY PINES ROAD, SUITE 140, LA JOLLA, CA, 92037
Open-market buys, last 90 days
$6,347,357
in 7 filings
Open-market sales, last 90 days
$279,010
in 2 filings

Net +$6,068,347. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. Lappe Mark +$4.5M Chief Executive Officer 3 filings
  2. Kayyem Jon Faiz +$1.6M Director 3 filings
  3. FORSYTH DOUGLAS +$287K Director 1 filing
  4. MANHARD KIMBERLY −$279K Director sold 25% of stake
Date Insider Transaction Shares Price Value Owned after
2026-09-15 MANHARD KIMBERLY Director Sale −500 $105.05 $53K 7,500
2026-09-14 MANHARD KIMBERLY Director Sale −500 $110.26 $55K 8,000
2026-09-11 MANHARD KIMBERLY Director Sale −500 $111.78 $56K 8,500
2026-09-09 MANHARD KIMBERLY Director Sale −500 $115.80 $58K 9,000
2026-09-08 MANHARD KIMBERLY Director Sale −500 $115.14 $58K 9,500
2025-10-07 VIKING GLOBAL INVESTORS LP 10% owner Sale −308,643 $32.25 $10.0M 1,267,823
2025-10-07 VIKING GLOBAL INVESTORS LP 10% owner Sale −16,315 $32.25 $526K 67,018
2025-10-07 VIKING GLOBAL INVESTORS LP 10% owner Sale −25,042 $32.25 $808K 102,864

Page 1 of 1 · 8 trades